Results for tag: "Dimethyltubocurarinium Chloride"

Dimethyltubocurarinium Chloride (DTC) is a drug used to treat musculoskeletal disorders. It is a neuromuscular blocking agent, meaning it blocks the transmission of nerve impulses to the muscles. It is used to treat conditions such as myasthenia gravis, a chronic autoimmune disorder that causes muscle weakness. It is also used to treat muscle spasms, muscle pain, and other conditions. DTC is administered intravenously or intramuscularly. The DTC market is driven by the increasing prevalence of musculoskeletal disorders, the growing demand for effective treatments, and the availability of generic versions of the drug. The market is also driven by the increasing number of clinical trials and research studies being conducted on the drug. Some companies in the DTC market include Mylan, Teva Pharmaceuticals, Pfizer, and Merck. Show Less Read more